One delay column solution helps laboratories simplify workflows, reduce system interference and future-proof PFAS methods for emerging compounds

TORRANCE, CA, - Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, today announced the launch of the PFAS Universal Delay Column, a new addition to its Designed for PFAS portfolio that helps analytical laboratories address one of the most persistent challenges in PFAS testing:  background system contamination and evolving compound panels. The new delay column provides comprehensive coverage across long, short and ultra-short-chain PFAS compounds in a single configuration, simplifying workflows while supporting emerging regulatory and analytical requirements.

"The PFAS testing landscape continues to evolve rapidly, with laboratories facing increasing pressure to detect a broader range of compounds at ever-lower levels," said Eric Lavold, Vice President of Product Management & Strategy at Phenomenex. "The PFAS Universal Delay Column was developed to help laboratories simplify their workflows while maintaining confidence in their results. By providing comprehensive PFAS coverage in a single delay column configuration setup, we are enabling customers to future-proof their methods and focus on generating reliable analytical data rather than managing multiple configurations."

The PFAS Universal Delay Column is designed for routine LC-MS/MS laboratories performing environmental, food, clinical, and toxicology PFAS analyses. It complements the broader Designed for PFAS portfolio, which provides scientists with workflow solutions for PFAS sample preparation, chromatographic separation, and analysis.

About Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being. Phenomenex is an operating company within the Life Sciences group of Danaher Corporation.

About Danaher
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve their most complex scientific and clinical challenges, helping move innovations from discovery to delivery faster for patients who depend on them. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. Explore more at www.danaher.com.​

Media Contact: Jannette Avila, Brand and Public Relations  |  jannettea@phenomenex.com